Study Stopped
no funding
Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
- 1.To determine the effect of spectacles with a red blocking filter on myopia progression in children.
- 2.To determine the effect of spectacles with a holographic diffuser that spreads incident light rays over an angle of 0.5 degrees on myopia progression in children
- 3.To determine the combined effects of spectacles with a red blocking filter and a diffuser that spreads incident light over an angle of 0.5 degrees on myopia progression in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2013
CompletedFirst Posted
Study publicly available on registry
August 15, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedAugust 14, 2019
August 1, 2019
4.1 years
August 13, 2013
August 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Myopia progression measured by rate of axial elongation of the eye
The axial length of both eyes will be measured before wearing the experimental eyeglasses, then once every three months thereafter for 18 months, and again 6 months after subjects stop wearing the study eye glasses. The rate of axial elongation will be calculated.
every 3 months for 18 months
Secondary Outcomes (1)
Myopia progression measured by cycloplegic autorefraction.
18 months
Study Arms (4)
color blocking tint
EXPERIMENTALSpectacles with red-blocking tint subjects will wear glasses daily for 6 months and have
holographic diffuser
OTHERSpectacles with color neutral tint subjects will wear glasses daily for 6 months and have
diffuser & color blocking tint
OTHERSpectacles with holographic diffuser and red-blocking tint subjects will wear glasses daily for 6 months and have
holographic diffuser and neutral tint
OTHERSpectacles with holographic diffuser and color neutral tint subjects will wear glasses daily for 6 months and have
Interventions
Eyeglasses will have lenses that will correct refractive error for each subject, and will have a tint that blocks red light.
Eyeglasses will correct refractive error for each subject but will have a holographic diffuser applied to the surface and will have a color neutral filter to adjust the light intensity reaching the eyes to be the same as for groups 1 and3.
Eyeglasses will correct refractive error for each subject and will be tinted to block red light, and will have a holographic diffuser to blur the image.
Eyeglasses will correct refractive error for each subject and will have a color neutral tint to adjust the light intensity reaching the eyes so it is the same as for groups 1 and 3.
Eligibility Criteria
You may qualify if:
- nearsighted having a refractive error of at least -0.5 diopters
- myopia progression at least -.50 D per year in previous year
- astigmatism and anisometropia not more than 1.5 D
- distance monocular acuity 6/6 or better
- near monocular acuity of 0.4 M or better
- stereoacuity not more than 40 sec of arc at 40 cm
- able to respond to subjective testing
- no contact lens use during the study
- able to comply with wearing the experimental lenses daily for 18 months
- able to have axial length measurements accurately on the Zeiss Intraocular Lens Master
- willing to donate a blood sample or a buccal swab for genetic analysis
- can be refracted to 20/20 or 20/15
You may not qualify if:
- glaucoma, amblyopia, strabismus
- ocular disease
- developmental delay
- history of wearing bifocal lenses
- any type of eye surgery
- color vision deficiency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Seattle Children's Hospitalcollaborator
Study Sites (1)
University of Washington
Seattle, Washington, 98109, United States
Related Publications (9)
Carkeet A, Saw SM, Gazzard G, Tang W, Tan DT. Repeatability of IOLMaster biometry in children. Optom Vis Sci. 2004 Nov;81(11):829-34. doi: 10.1097/01.opx.0000145020.33250.c0.
PMID: 15545808BACKGROUNDCongdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003 Oct 15;290(15):2057-60. doi: 10.1001/jama.290.15.2057. No abstract available.
PMID: 14559961BACKGROUNDGrosvenor T. Why is there an epidemic of myopia? Clin Exp Optom. 2003 Sep;86(5):273-5. doi: 10.1111/j.1444-0938.2003.tb03122.x. No abstract available.
PMID: 14558848BACKGROUNDGwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. doi: 10.1167/iovs.02-0816.
PMID: 12657584BACKGROUNDIp JM, Rose KA, Morgan IG, Burlutsky G, Mitchell P. Myopia and the urban environment: findings in a sample of 12-year-old Australian school children. Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3858-63. doi: 10.1167/iovs.07-1451. Epub 2008 May 9.
PMID: 18469186BACKGROUNDRein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754.
PMID: 17159036BACKGROUNDSaw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005 Sep;25(5):381-91. doi: 10.1111/j.1475-1313.2005.00298.x.
PMID: 16101943BACKGROUNDSaw SM, Katz J, Schein OD, Chew SJ, Chan TK. Epidemiology of myopia. Epidemiol Rev. 1996;18(2):175-87. doi: 10.1093/oxfordjournals.epirev.a017924. No abstract available.
PMID: 9021311BACKGROUNDVitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009 Dec;127(12):1632-9. doi: 10.1001/archophthalmol.2009.303.
PMID: 20008719BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jay Neitz, PhD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 13, 2013
First Posted
August 15, 2013
Study Start
November 1, 2013
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
August 14, 2019
Record last verified: 2019-08